home page

About the Journal

About the Journal

The Current Pharmaceutical Letters and Reviews (CPLR) is a prestigious, open-access journal dedicated to the dissemination of innovative research and comprehensive reviews across various medical disciplines. Our mission is to advance both general and scientific medical research, as well as clinical practice. CPLR welcomes contributions from a broad range of specialties, including but not limited to Cardiology, Neurology, Obstetrics and Gynecology, Surgery, Internal Medicine, Orthopedics, Infectious Diseases, HIV/AIDS, and Oncology.

We invite researchers to submit their well-crafted studies, innovative topics, and recent advancements in the clinical and medical fields. Submissions may take the form of original research articles or comprehensive reviews. By fostering collaboration and the exchange of knowledge, CPLR aims to be a vital platform for showcasing groundbreaking research and promoting excellence in healthcare practices.

All articles published in CPLR are freely accessible online immediately upon publication. We invite researchers, scholars, academicians, industry professionals, and consulting firms to share their outstanding work to further the advancement of science and technology.

Journal Standards:

  • Renowned editorial board from around the world.
  • Rapid email alert updates.
  • Indexed in a variety of databases maintained by reputable international publishers.
  • Comprehensive online access, free for readers.
  • Fast online manuscript submission process.
  • Certificate of publication available upon request.
  • No subscription costs; all published papers are freely available online immediately upon publication.
  • Rapid publishing process and extensive exposure for published works.

We encourage you to contribute to CPLR and join us in promoting cutting-edge research and excellence in the medical field.

Current Issue

CPLR: Number 1 , Vol. 1, October 2024
View CPLR: Number 1 , Vol. 1, October 2024
Published: 2024-11-09

Articles

View All Issues